GlaxoSmithKline Pharmaceuticals board to consider unaudited financial results

08 Apr 2014 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on April 17, 2014, to consider approval of unaudited financial results for the quarter ended March 31, 2014 (Q1).

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2338.20 30.20 (1.31%)
25-Mar-2026 09:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.20
Dr. Reddys Lab 1276.20
Cipla 1225.00
Zydus Lifesciences 892.00
Lupin 2349.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×